Jin Haoxing, Parker Walter T, Law Nathan W, Clarke Cameron L, Gisseman Jordan D, Pflugfelder Stephen C, Wang Li, Al-Mohtaseb Zaina N
Department of Ophthalmology, School of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA.
Br J Ophthalmol. 2017 Nov;101(11):1483-1487. doi: 10.1136/bjophthalmol-2016-310026. Epub 2017 Mar 23.
To identify the risk factors, causative organisms, antimicrobial susceptibility and outcomes of microbial keratitis in a large county hospital in Houston, Texas. Case series.
Setting: A large county hospital in Houston, Texas.
Patients with known diagnosis of microbial keratitis from January 2011 to May 2015.
Retrospective chart review.
Epidemiology, risk factors, outcomes and antibiotic susceptibility of microbial keratitis.
The most commonly identified risk factors were contact lens use (34.4%), ocular trauma (26.3%), diabetes mellitus (16.7%), ocular surgery (13.5%), ocular surface diseases (11.5%), previous keratitis (10.4%), glaucoma (6.3%), cocaine use (5.2%) and HIV-positive status (4.2%). Eyes with positive cultures (61.5%) were associated with worse visual outcomes (p=0.019) and a higher number of follow-up visits (p=0.007) than eyes with negative cultures (38.5%). Corneal perforation was the most common complication (11.5%). Gram-negative organisms (21.9%) were all susceptible to ceftazidime, tobramycin and fluoroquinolones. Gram-positive organisms (33.3%) had worse outcomes than Gram-negative organisms (21.9%) and exhibited a wide spectrum of antibiotic resistance, but all were susceptible to vancomycin. Twenty-seven per cent of the coagulase-negative were resistant to fluoroquinolones.
This study identified a recent shift in risk factors and antibiotic resistance patterns in microbial keratitis at a County Hospital in Houston, Texas. In our patient population, fluoroquinolone monotherapy is not recommended for severe corneal ulcers. On the basis of these results, vancomycin and tobramycin should be used for empirical therapy until microbial identity and sensitivity results are available.
为确定德克萨斯州休斯顿一家大型县医院微生物性角膜炎的危险因素、致病微生物、抗菌药物敏感性及预后情况。病例系列研究。
研究地点:德克萨斯州休斯顿一家大型县医院。
2011年1月至2015年5月确诊为微生物性角膜炎的患者。
回顾性病历审查。
微生物性角膜炎的流行病学、危险因素、预后及抗生素敏感性。
最常确定的危险因素为隐形眼镜使用(34.4%)、眼外伤(26.3%)、糖尿病(16.7%)、眼科手术(13.5%)、眼表疾病(11.5%)、既往角膜炎(10.4%)、青光眼(6.3%)、使用可卡因(5.2%)及HIV阳性状态(4.2%)。培养结果阳性的眼(61.5%)与培养结果阴性的眼(38.5%)相比,视力预后较差(p=0.019)且随访次数更多(p=0.007)。角膜穿孔是最常见的并发症(11.5%)。革兰阴性菌(21.9%)对头孢他啶、妥布霉素和氟喹诺酮类均敏感。革兰阳性菌(33.3%)的预后比革兰阴性菌(21.9%)差,且表现出广泛的抗生素耐药性,但对万古霉素均敏感。27%的凝固酶阴性菌对氟喹诺酮类耐药。
本研究确定了德克萨斯州休斯顿一家县医院微生物性角膜炎的危险因素及抗生素耐药模式的近期变化。在我们的患者群体中,不推荐对严重角膜溃疡使用氟喹诺酮类单药治疗。基于这些结果,在获得微生物鉴定和药敏结果之前,应使用万古霉素和妥布霉素进行经验性治疗。